Phase 1 study of KBP-7026 for asthma/COPD

Trial Profile

Phase 1 study of KBP-7026 for asthma/COPD

Phase of Trial: Phase I

Latest Information Update: 10 Jan 2018

At a glance

  • Drugs KBP-7026 (Primary)
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top